
Adam Christopher ElNaggar MD MD (He/Him)
Genitourinary Oncology, Gynecologic Cancer
Medical Director, Gynecologic Oncologist
Join to view full profile
201 Industrial RdSan Carlos, CA 94070
Dr. ElNaggar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2013 - 2016
University of Tennessee College of Medicine (Memphis)Residency, Obstetrics and Gynecology, 2009 - 2013
Indiana University School of MedicineClass of 2009
Anderson University - IndianaB.A., Biochemistry, 2000 - 2004
Certifications & Licensure
AR State Medical License 2016 - 2024
OH State Medical License 2013 - 2023
TN State Medical License 2016 - 2023
MS State Medical License 2016 - 2022
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- 2013 Roy M. Pitkin Award 2014
- Excellence in Gynecologic Oncology 2013
- Resident Achievement Award Society of Laparoendoscopic Surgeons, 2013
Publications & Presentations
PubMed
- 6 citationsOlaparib as treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency: Phase 2 LIGHT study final overall surviv...Ying L Liu, Cara A Mathews, Fiona Simpkins, Karen A Cadoo, Diane Provencher
Cancer. 2025-01-15 - 8 citationsLongitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma.Arnab Basu, Cherry Au, Ajitha Kommalapati, Hyndavi Kandala, Sumedha Sudhaman
JCO Precision Oncology. 2024-12-01 - 21 citationsAssociation of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma.Andres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu, Ryan M Winters, Mustafa Balcioglu
The Oncologist. 2024-10-03
Journal Articles
- A Comparison of Outcomes following Robotic-Assisted Staging and Laparotomy in patients with Early Stage Endometrioid Adenocarcinoma of the Uterus with Uterine Weight U...Ulm, M.A., Ginn, D.N., ElNaggar, A.C., Tillmanns, T.D., Reed, K.M., Wan, J.Y., Watson, C.H., Dedania, S.J., Reed, M.E., Gynecology and Minimally Invasive Therapy, 1/1/2016
- "Effect of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting Associated With Robotic Gynecologic Surgery: A Randomized, Double-Blinded, P...Lee, D., Tillmanns, T.D., Ulm, M., Mabe, A., Kumar, S., ElNaggar, A.C., Journal of Gynecologic Surgery, 1/1/2015
Abstracts/Posters
- Close vulvar cancer margins are not strongly associated with recurrence or survival.C. Cosgrove, A. ElNaggar, M. Ulm, R. Sarin, E. Hade, P. Blackburn, T. Tillmanns, M. Reed, D. Cohn, J. Fowler., Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
- Neo-adjuvant chemotherapy for the treatment of stage IV endometrial adenocarcinoma: A retrospective cohort.A. ElNaggar, R. Neff, M. Ulm, L. Lambrecht, U. Naeem, S. Pollock, J. Fowler, D. Cohn, F. Backes, T. Tillmanns, Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
- Recurrence in obese patients with stage I endometrioid endometrial cancer: Does para-aortic lymph node dissection matter?C. Watson, A. ElNaggar, T. Tillmanns, M. Ulm, Featured Posters I & II: Meet the Professor Reception: Connecting Minds for a Better Future, Society of Gynecologic Oncology Annual Meeting, National Harbor, MD, 1/1/2017
Lectures
- A randomized controlled trial comparing the efficacy of perioperative celecoxib versus ketorolac for perioperative pain control.National Harbor, MD - 1/1/2017
- "Ovarian Cancer: Update on Screening"Memphis, TN - 1/1/2017
- "Prevention of Lower Genital Tract Malignancies"Grant Medical Center, Columbus, OH - 1/1/2016
Press Mentions
Signatera™ Surveillance Testing Identified 100% of Uterine Cancer Recurrences in Advance of Imaging, New Study ShowsSeptember 29th, 2025
Professional Memberships
- Member
- Society of Gynecologic OncologyMember
- American Association of Cancer ResearchMember
- American Society of Clinical OncologistsMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









